USPTO serial 79297749
DIACEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 7, 2021
- Examiner
- LAWRENCE, SUSAN KASTRINER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DIACEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes | ACTIVE | — |
| 009 | Downloadable computer software used in respect of medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data; downloadable computer software for use in relation to business networking and content management; downloadable computer software applications delivered to any computing device including desktop, laptop and tablet computers as well as mobile devices for data management and visualisation, for generating reports, charts and dashboards | ACTIVE | — |
| 035 | Business consultancy and advisory services; provision of business information and business management services to laboratory networks and diagnostic and pharmaceutical companies; compilation of information, statistics and data into computer databases relating to medicine and pharmaceutical testing, research and development services; business data analysis; advisory and consultancy services relating to business intelligence and business industry research; compilation of information into computer databases; providing information regarding business intelligence and business industry research via a website | ACTIVE | — |
| 042 | Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; medical research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of medical diagnostic preparations; design and development of computer databases; design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; software as a service (SaaS) services featuring non-downloadable software for data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; software as a service (SaaS) services featuring non-downloadable software enabling communication between laboratory networks and diagnostic and pharmaceutical companies; software as a service (SaaS) services featuring non-downloadable software for data management and visualisation, including generating reports, charts and dashboards; platform as a service (PaaS) services featuring non-downloadable software platforms for data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; platform as a service (PaaS) services featuring non-downloadable software platforms enabling communication between laboratory networks and diagnostic and pharmaceutical companies; platform as a service (PaaS) services featuring non-downloadable software platforms for data management and visualisation, including generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Diaceutics Plc
- Other trademarks owned by Diaceutics Plc
- Other trademarks owned by Diaceutics Plc
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named DIACEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 23, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 23, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 7, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 21, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 21, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 1, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 23, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |